
Nascent Biotech, Inc.
OTC:NBIO
0.2 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 0.372 | 0.172 | 0.094 | 0.001 | 0.003 | 0.131 | 0.117 | 0.13 | 0.573 | 0.108 | 0.114 | 0 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.372 | 0.172 | 0.094 | 0.001 | 0.003 | 0.131 | 0.117 | 0.13 | 0.573 | 0.108 | 0.114 | 0 |
Net Receivables
| 0 | 0 | 0 | 0.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.18 | 0.083 | 0.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0.001 | 0.004 |
Total Current Assets
| 0.552 | 0.255 | 0.105 | 0.751 | 0.003 | 0.131 | 0.117 | 0.13 | 0.573 | 0.11 | 0.115 | 0.005 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.77 | 0.828 | 0.828 | 0 | 0 |
Total Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.77 | 0.828 | 0.828 | 0 | 0.001 |
Total Assets
| 0.552 | 0.255 | 0.105 | 0.751 | 0.003 | 0.131 | 0.117 | 0.9 | 1.401 | 0.938 | 0.115 | 0.006 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 0.686 | 0.498 | 0.777 | 0.538 | 0.739 | 0.526 | 0.203 | 0.152 | 2.339 | 1.276 | 0.089 | 0 |
Short Term Debt
| 0.123 | 0.39 | 0 | 0.162 | 0.139 | 0 | 0 | 0 | 0 | 0 | 0 | 0.152 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0.123 | 1.284 | 0 | 0 | 0 | 0.6 | 0 | 0 | 0 |
Other Current Liabilities
| 0 | 0.663 | 0 | 0.524 | 2.001 | 0.088 | 0 | 0.014 | 0.031 | 1.809 | 1.477 | 1.8 |
Total Current Liabilities
| 0.809 | 1.551 | 0.777 | 1.224 | 2.879 | 0.614 | 0.203 | 0.166 | 2.97 | 3.085 | 1.565 | 1.952 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 0 | 0.777 | 0 | 0 | 0.526 | 0.203 | 0.152 | 0.6 | 0.06 | 0.01 | 0.42 |
Total Liabilities
| 0.809 | 1.551 | 0.777 | 1.224 | 2.879 | 0.614 | 0.203 | 0.166 | 2.97 | 3.145 | 1.565 | 1.952 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
Common Stock
| 0.171 | 0.132 | 0.111 | 0.105 | 0.045 | 0.033 | 0.028 | 0.023 | 0.022 | 0.018 | 0.007 | 0.003 |
Retained Earnings
| -24.26 | -21.623 | -18.822 | -18.351 | -16.838 | -12.833 | -11.465 | -9.243 | -10.38 | -6.231 | -4.079 | -2.162 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0 |
Other Total Stockholders Equity
| 23.833 | 20.195 | 18.039 | 17.774 | 13.917 | 12.319 | 11.35 | 9.954 | 8.79 | 4.007 | 2.632 | 0.213 |
Total Shareholders Equity
| -0.257 | -1.296 | -0.671 | -0.473 | -2.876 | -0.482 | -0.086 | 0.734 | -1.569 | -2.207 | -1.45 | -1.946 |
Total Equity
| -0.257 | -1.296 | -0.671 | -0.473 | -2.876 | -0.482 | -0.086 | 0.734 | -1.569 | -2.207 | -1.45 | -1.946 |
Total Liabilities & Shareholders Equity
| 0.552 | 0.255 | 0.105 | 0.751 | 0.003 | 0.131 | 0.117 | 0.9 | 1.401 | 0.938 | 0.115 | 0.006 |